Schizophrenia Stocks List

Recent Signals

Date Stock Signal Type
2019-10-17 ACAD Narrow Range Bar Range Contraction
2019-10-17 ACAD NR7 Range Contraction
2019-10-17 ATHX 180 Bullish Setup Bullish Swing Setup
2019-10-17 ATHX Bollinger Band Squeeze Range Contraction
2019-10-17 ATHX Crossed Above 50 DMA Bullish
2019-10-17 ATHX Crossed Above 20 DMA Bullish
2019-10-17 AZN 50 DMA Resistance Bearish
2019-10-17 AZN Crossed Above 20 DMA Bullish
2019-10-17 BLRX Shooting Star Candlestick Bearish
2019-10-17 BLRX 50 DMA Resistance Bearish
2019-10-17 BLRX Fell Below 20 DMA Bearish
2019-10-17 BLRX Expansion Pivot Sell Setup Bearish Swing Setup
2019-10-17 BLRX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-17 BMY Upper Bollinger Band Walk Strength
2019-10-17 CNCE 1,2,3 Retracement Bearish Bearish Swing Setup
2019-10-17 CNCE Doji - Bearish? Reversal
2019-10-17 CNCE Pocket Pivot Bullish Swing Setup
2019-10-17 CNCE Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-17 DRRX Crossed Above 20 DMA Bullish
2019-10-17 ENDP Expansion Breakout Bullish Swing Setup
2019-10-17 ENDP Wide Range Bar Range Expansion
2019-10-17 ENDP Volume Surge Other
2019-10-17 ENDP Pocket Pivot Bullish Swing Setup
2019-10-17 ITCI Narrow Range Bar Range Contraction
2019-10-17 ITCI Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-17 NBIX Expansion Pivot Buy Setup Bullish Swing Setup
2019-10-17 NBIX Crossed Above 50 DMA Bullish
2019-10-17 NBIX Pocket Pivot Bullish Swing Setup
2019-10-17 NBIX Stochastic Reached Overbought Strength
2019-10-17 NERV Narrow Range Bar Range Contraction
2019-10-17 TTNP New 52 Week Low Weakness
2019-10-17 TTNP Calm After Storm Range Contraction
2019-10-17 TTNP MACD Bearish Signal Line Cross Bearish
2019-10-17 TTNP Stochastic Reached Oversold Weakness
2019-10-17 TTNP New 52 Week Closing Low Bearish
2019-10-17 TTNP Narrow Range Bar Range Contraction
2019-10-17 TTNP Volume Surge Other
2019-10-17 VNDA Pocket Pivot Bullish Swing Setup
2019-10-17 VNDA Narrow Range Bar Range Contraction
2019-10-17 VNDA Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-17 XTLB MACD Bullish Signal Line Cross Bullish
2019-10-17 XTLB Fell Below 20 DMA Bearish
2019-10-17 XTLB Narrow Range Bar Range Contraction
2019-10-17 ZGNX Expansion Pivot Buy Setup Bullish Swing Setup
2019-10-17 ZGNX Pocket Pivot Bullish Swing Setup
2019-10-17 ZGNX Crossed Above 50 DMA Bullish
2019-10-17 ZGNX Crossed Above 200 DMA Bullish

Schizophrenia is a mental disorder characterized by abnormal behavior, strange speech and a decreased ability to understand reality. Other symptoms include false beliefs, unclear or confused thinking, hearing voices that do not exist, reduced social engagement and emotional expression and lack of motivation. People with schizophrenia often have additional mental health problems such as anxiety, depressive or substance-use disorders. Symptoms typically come on gradually, begin in young adulthood and in many cases never resolve.The causes of schizophrenia include environmental and genetic factors. Possible environmental factors include being raised in a city, cannabis use during adolescence, certain infections, the age of a person's parents, and poor nutrition during pregnancy. Genetic factors include a variety of common and rare genetic variants. Diagnosis is based on observed behavior, the person's reported experiences and reports of others familiar with the person. During diagnosis, a person's culture must also be taken into account. As of 2013, there is no objective test. Schizophrenia does not imply a "split personality" or dissociative identity disorder, conditions with which it is often confused in public perception.The mainstay of treatment is antipsychotic medication, along with counselling, job training and social rehabilitation. It is unclear whether typical or atypical antipsychotics are better. In those who do not improve with other antipsychotics, clozapine may be tried. In more serious situations where there is risk to self or others, involuntary hospitalization may be necessary, although hospital stays are now shorter and less frequent than they once were.About 0.3% to 0.7% of people are affected by schizophrenia during their lifetimes. In 2013, there were an estimated 23.6 million cases globally. Males are more often affected and on average experience more severe symptoms. About 20% of people eventually do well, and a few recover completely; about 50% have lifelong impairment. Social problems, such as long-term unemployment, poverty and homelessness, are common. The average life expectancy of people with the disorder is 10–25 years less than that of the general population. This is the result of increased physical health problems and a higher suicide rate (about 5%). In 2015, an estimated 17,000 people worldwide died from behavior related to, or caused by, schizophrenia.

More about Schizophrenia